Orchestra BioMed’s hypertension treatment is the latest medical device to earn the FDA’s breakthrough designation. Medtronic has a commercialization deal with the company for the device, which uses a pacing algorithm to actively lower blood pressure in people with pacemakers.
Other participants included Enzia Ventures and ITI Growth Opportunities Fund, along with existing investors Chiratae Ventures and Omidyar Network India
Hyderabad: Integrated digital health startup EkinCare on Tuesday said it raised a strategic, undisclosed investment led by global healthcare giant MSD.
Lifesigns and Cura Hospital bridge urban-rural healthcare gap with AI
April has seen a slew of executive hires, exits and layoffs across the healthcare industry. For example, AdventHealth and DexCare both named new CEOs, and…
Regulus Therapeutics drug farabursen is a potential first-in-class treatment for a rare kidney disease whose only FDA-approved therapy introduces severe toxicity risks. Farabursen is joining…
Several states and insurers have gold carding programs to streamline prior authorization. However, some say they’re falling short.
The mandatory CMS TEAM program begins next year. Are you ready? As hospitals consider their options for addressing the mandate, here are some actions to…
After selling off a portion of its diabetes care business last year, Ypsomed is now fully exiting the diabetes care business with a plan to…
Generally, the standard treatment for solid tumors is surgery. However, a recent study from New York City-based Memorial Sloan Kettering Cancer Center found immunotherapy can…
Pixee Medical, an orthopedic, surgery-focused, augmented-reality technology company, has earned FDA clearance for its Knee+ NexSight AR guidance system for total knee arthroplasty. The technology…
